Concepedia

Publication | Open Access

ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study

38

Citations

8

References

2022

Year

Abstract

NCT02325557.

References

YearCitations

Page 1